Thorsten Graef
Hematologist-Oncologist | Hematology & Oncology
995 East Arques Avenue Sunnyvale California, 94085About
Thorsten Graef, MD, is the head of hematology and global medical safety at Pharmacyclics in Sunnyvale, CA. With over 13 years of experience, he holds extensive expertise in hematology, oncology and research administration. He was educated at Heinrich Heine University D�sseldorf, where he obtained a medical degree and a PhD in Molecular Biology. Furthermore, he went on to complete a residency at Stanford Health Care. In order to stay current on developments in his field, Dr. Graef maintains professional memberships with the European Hematology Association and The American Society of Hematology.
Thorsten Graef's Videos
Education and Training
MD at Heinrich Heine University D�sseldorf
Provider Details
Areas of expertise and specialization
Faculty Titles & Positions
- International Public Speaking -
Professional Society Memberships
- European Hematology Association, The American Society of Hematology
Articles and Publications
- Published
What do you attribute your success to?
- Vision for having a large impact through research and development.
Hobbies / Sports
- Basketball
Favorite professional publications
- New England Journal of Medicine, Journal of Oncology
Thorsten Graef's Practice location
Thorsten Graef's reviews
Write ReviewRecommended Articles
- What are the Stages of Multiple Myeloma?
This is the uncommon type of cancer that forms in plasma cells. A type of white blood cells found in the body, plasma cells, identify and battle germs and infections that attack the body.In multiple myeloma patients, the healthy plasma cells are overtaken by cancer cells. This reduces the number of...
- Breaking News on the Treatment of Follicular Lymphoma
Reuters, the international news agency out of London, has announced that the FDA has given a new drug “accelerated approval,” for the treatment of follicular lymphoma.The drug, Aliqopa (copanlisib), showed complete or partial shrinkage of tumors in 59% of study participants during drug studies,...
- Astonishing Clinical Trial Results Show Promise for Non-Hodgkin Lymphoma Research
There’s good news for those who’ve been diagnosed with the aggressive non-Hodgkin lymphoma (NHL) type referred to as diffuse large-B cell (DLBCL). According to the American Cancer Society (ACS), this type of HNL is the most common type of lymphoma.The descriptive letters clarify the type of...
- The Link Between Lymphoma Radiotherapy and Mesothelioma
One of the more common forms of treatment for lymphoma is radiotherapy. This involves using radiation to kill the cancer cells in the lymph nodes. New studies have produced concerning findings regarding radiation therapy, and point towards another induced risk of using the practice.The StudyThe...
- Living with Lymphoma Day by Day
A majority of individuals diagnosed with lymphoma find that they have to make a great deal of adjustments to their lives. There are several physical, emotional, social, and everyday obstacles from diagnosis to remission.Living with lymphoma can be different for every individual, which is why it is...
- How Dogs Are Helping with Lymphoma Research
According to the Cornell Chronicle (CC), Cornell and Tufts University have received a huge grant for the study of human lymphoma, using a humane approach to test on dogs.The dogs in the study will already have lymphoma and it’s hoped they’ll be cured in the process of this research study.There...
Nearby Providers
- Dr. Joseph Andrew Mollick M.D.875 Blake Wilbur Drive, Mc5820 Stanford CA 94305
- Dr. Peter Samuel Galatin M.D., PH.D.2585 Samaritan Dr San Jose CA 95124
- Dr. Saul Rosenberg M.D.269 Campus Dr Stanford CA 94305
- Dr. Rondeep Singh Brar M.D.300 Pasteur Dr Palo Alto CA 94304
- Dr. Alexander Dimitrios Colevas MD875 Blake Wilbur Drive Stanford CA 94305
- Dr. Wen-kai Weng M.D., PH.D.300 Pasteur Dr Stanford CA 94305